Nathaniel Oswald, MD
Payments from drug & device makers
What this record shows
This record is dominated by education: $3,000 of the $4,894 with a category attached, or 61.3%. Intuitive Surgical accounts for 61.3% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $3,289, more than ten times the $116 reported in 2021.
Across 32 payments — averaging $152.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Boston Scientific$904
- Coloplast$232
- Axonics, Inc.$204
- Teleflex LLC$160
- Innovation Technologies Inc$150
- plus $244 from 5 others
What the payments were for
- Food & beverage$1,89439%
- Education$3,00061%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $3,000 |
| Boston Scientific | 16 | $904 |
| Coloplast | 3 | $232 |
| Axonics, Inc. | 3 | $204 |
| Teleflex LLC | 2 | $160 |
| Innovation Technologies Inc | 1 | $150 |
| Olympus America Inc. | 1 | $138 |
| Palette Life Sciences, Inc. | 1 | $33 |
| Cook Medical LLC | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Procept Biorobotics Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- SpaceOAR VUE System - 10mL$460
- UroLift$153
- Irrisept$150
- iTIND System$138
- AMS 700$124
- TITAN$116
- Bulkamid$116
How this compares
$4,894 in reported general payments places this provider in the 55th percentile of 96 urology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 18 | $8,984 |
| Trospium Chloride | 19 | $744 |
| Tamsulosin Hcl | 47 | $638 |
| Methenamine Hippurate | 18 | $539 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $194 |
| Ciprofloxacin Hcl | 12 | $109 |
| Doxycycline Hyclate | 14 | $104 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $75 |
| Oxycodone Hcl | 15 | $18 |
Paid to pharmacies, not to this prescriber.
Other urology in Provo
- Jeffrey SparenborgProvo$37K
- Jim CrowleyProvo$8K
- McKay PlattProvo$5K
- Matthew SwallowProvo$4K
- Kyle GarciaProvo$2K
- Steven GangeSlc$1.5M
- William BrantSalt Lake City$290K
- Roscoe NelsonAmerican Fork$152K
- Nathan PursifullAmerican Fork$86K
- Benjamin McCormickSalt Lake City$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.